Piper Sandler Raises UnitedHealth Price Target Ahead of Q3 Earnings
UnitedHealth Group (UNH) is set to report third-quarter earnings on October 28, with Piper Sandler analyst Jessica Tassan increasing the stock's price target to $423 from $280 while maintaining a Buy rating. Tassan cited confidence in UNH's ability to meet its guidance despite a 28% year-to-date decline in shares, driven by rising medical costs and a Department of Justice probe.
Wall Street anticipates a 61% drop in earnings per share (EPS) to $2.82 for Q3, though revenue is expected to grow 12% to $113.04 billion. Tassan highlighted UnitedHealth's proactive adjustments to its 2025 and 2026 earnings guidance as a strategic MOVE amid pressures in Medicare, Commercial, and Medicaid segments.